-
2 months ago | 
nature.com | Kelsey Swingle |Alex Hamilton |Ajay S. Thatte |Amanda Murray |Emily Han |Xuexiang Han | +2 more
Correction to: Nature https://doi.org/10.1038/s41586-024-08291-2 Published online 11 December 2024In the version of the article initially published, in Fig. 2b, the x-axis label “µg β2-GPI per µg lipid” has now been amended to “µg ApoE per µg lipid”. In Fig. 2d, the x-axis label “µg ApoE per µg lipid” has now been amended to “µg β2-GPI per µg lipid”. In the key for Figs. 3e–j, “LNP + LNP 55” was incorrect and has now been amended to “LPS + LNP 55”.
-
Dec 11, 2024 | 
nature.com | Kelsey Swingle |Alex Hamilton |Ajay S. Thatte |Amanda Murray |Emily Han |Xuexiang Han | +2 more
AbstractPre-eclampsia is a placental disorder that affects 3–5% of all pregnancies and is a leading cause of maternal and fetal morbidity worldwide1,2. With no drug available to slow disease progression, engineering ionizable lipid nanoparticles (LNPs) for extrahepatic messenger RNA (mRNA) delivery to the placenta is an attractive therapeutic option for pre-eclampsia.
-
May 17, 2024 | 
pulmonologyadvisor.com | Anastasia Climan |Naveed Saleh |Amanda Murray |Brandon May
ATS Pulmonary Rehabilitation Guidelines: RT Is Essential but Underused Protecting Youth From the Dangers of Vaping: What’s Been Done, What’s Needed ERS 2023 Spotlights Emerging Pharmacotherapies Research As Vaping Among Teens, Young Adults Rapidly Increases, So Do Health Concerns Current Wildfire Season Raises Nationwide Concern for Protecting Lung Health Clinical Tools Powered by
-
Oct 27, 2023 | 
neurologyadvisor.com | Amanda Murray
Recalls on digoxin tablets and devices used for the inflation and deflation of aortic balloons have been the focus of cardiology-related Food and Drug Administration (FDA) MedWatch safety alerts this summer.
-
Oct 24, 2023 | 
thecardiologyadvisor.com | Amanda Murray
The Centers for Disease Control and Prevention (CDC) offered clinical guidance on preventing respiratory syncytial virus (RSV) in infants via a webinar hosted by the CDC Wednesday, September 27, 2023.
-
Oct 19, 2023 | 
brnw.ch | Amanda Murray
At the North American Menopause Society 2023 Annual Meeting from September 27 to 30 in Philadelphia, Pennsylvania, many studies focused on emerging therapies for the management of menopausal vasomotor symptoms. Effects of Estetrol on Lipid and Carbohydrate Metabolism Estetrol yields beneficial effects on the lipid profile and carbohydrate metabolism among individuals after menopause.
-
Oct 19, 2023 | 
clinicaladvisor.com | Amanda Murray
At the North American Menopause Society 2023 Annual Meeting from September 27 to 30 in Philadelphia, Pennsylvania, many studies focused on emerging therapies for the management of menopausal vasomotor symptoms. Effects of Estetrol on Lipid and Carbohydrate Metabolism Estetrol yields beneficial effects on the lipid profile and carbohydrate metabolism among individuals after menopause.
-
Oct 17, 2023 | 
ophthalmologyadvisor.com | Amanda Murray
The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has adopted the recommendation for maternal vaccination for respiratory syncytial virus (RSV) of pregnant individuals 32 to 36 weeks gestation, using seasonal administration, in order to prevent RSV lower respiratory tract infection in infants.1 The recommendation was made by the ACIP at a virtual meeting on Friday, September 22, 2023,1 which followed on the heels of Food and Drug...
-
Oct 13, 2023 | 
endocrinologyadvisor.com | Amanda Murray
At the North American Menopause Society 2023 Annual Meeting from September 27 to 30 in Philadelphia, Pennsylvania, many studies focused on emerging therapies for the management of menopausal vasomotor symptoms. Effects of estetrol on lipid and carbohydrate metabolism Estetrol yields beneficial effects on the lipid profile and carbohydrate metabolism among individuals after menopause.
-
Oct 10, 2023 | 
cancertherapyadvisor.com | Amanda Murray
The US Food and Drug Administration (FDA) approved several new treatments for a range of cancers over the summer. In July, the FDA approved a new indication for Jemperli (dostarlimab) in endometrial cancer. In August, the FDA granted accelerated approval for Talvey (talquetamab) and Elrexfio (elranatamab) to treat multiple myeloma.
